Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bio-Techne Cp (TECH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Shares of TECH Up 30.8% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on January 8th, 2019 at $147.26. In approximately 3 months, Bio-Techne Corp has returned 30.81% as of today's recent price of $192.62....

TECH : 194.19 (+0.96%)
Bio-Techne Corp Shares Up 32.9% Since SmarTrend's Buy Recommendation (TECH)

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on January 8th, 2019 at $147.26. In approximately 2 months, Bio-Techne Corp has returned 32.87% as of today's recent price of $195.66....

TECH : 194.19 (+0.96%)
Shares of TECH Up 28.7% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on January 8th, 2019 at $147.26. In approximately 2 months, Bio-Techne Corp has returned 28.66% as of today's recent price of $189.46....

TECH : 194.19 (+0.96%)
Bio-Techne Scores A Trio Of CiteAb 2019 Awards

Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, was honored with three prestigious 2019 CiteAb Awards....

TECH : 194.19 (+0.96%)
Bio-Techne To Present At The Barclays Global Healthcare Conference

Bio-Techne Corporation (NASDAQ:TECH) today announced that Jim Hippel, Chief Financial Officer will present at the Barclays Global Healthcare Conference on Wednesday, March 13th, 2019, at 9:00 a.m. EST....

TECH : 194.19 (+0.96%)
Report: Exploring Fundamental Drivers Behind Stericycle, B&G Foods, QTS Realty Trust, Trimble, Electronics for Imaging, and Bio-Techne -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Stericycle, Inc. (NASDAQ:SRCL),...

QTS : 44.25 (-0.20%)
EFII : 25.61 (-1.50%)
TECH : 194.19 (+0.96%)
TRMB : 39.45 (+0.05%)
SRCL : 51.72 (+2.44%)
BGS : 24.75 (+0.45%)
Uptrend Call Working As Bio-Techne Corp Stock Rises 32.0% (TECH)

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on January 8th, 2019 at $147.26. In approximately 2 months, Bio-Techne Corp has returned 31.96% as of today's recent price of $194.32....

TECH : 194.19 (+0.96%)
Bio-Techne Signs Strategic Cooperation Agreement with Lisen Imprinting Diagnostics

Bio-Techne has entered into a strategic cooperation agreement in the precision medicine field with Lisen Imprinting Diagnostics Wuxi Co., Ltd, China. Liwen Pei, Managing Director of Bio-Techne China, and...

TECH : 194.19 (+0.96%)
Uptrend Call Working As Bio-Techne Corp Stock Rises 31.5% (TECH)

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on January 8th, 2019 at $147.26. In approximately 1 month, Bio-Techne Corp has returned 31.52% as of today's recent price of $193.67.

TECH : 194.19 (+0.96%)
Bio-Techne (TECH) Q2 Earnings Beat, Gross Margin Declines

Bio-Techne (TECH) sees increase in revenues across key segments.

TECH : 194.19 (+0.96%)
ABT : 78.23 (+0.33%)
ANGO : 21.88 (+0.23%)
CNMD : 80.75 (+1.17%)
Bio-Techne Corp Shares Up 26.8% Since SmarTrend's Buy Recommendation (TECH)

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on January 8th, 2019 at $147.26. In approximately 1 month, Bio-Techne Corp has returned 26.75% as of today's recent price of $186.65.

TECH : 194.19 (+0.96%)
Bio-Techne Corp Up 24.1% Since SmarTrend Uptrend Call (TECH)

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on January 8th, 2019 at $147.26. In approximately 4 weeks, Bio-Techne Corp has returned 24.09% as of today's recent price of $182.73.

TECH : 194.19 (+0.96%)
Techne (TECH) Q2 Earnings and Revenues Surpass Estimates

Techne (TECH) delivered earnings and revenue surprises of 6.00% and 2.57%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

TECH : 194.19 (+0.96%)
Bio-Techne Declares Dividend

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended December 31, 2018. The quarterly dividend will be payable...

TECH : 194.19 (+0.96%)
Bio-Techne Releases Second Quarter Fiscal 2019 Results

Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2018.

TECH : 194.19 (+0.96%)
ExoDx® Prostate(IntelliScore) (EPI) Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection

Bio-Techne Corporation (NASDAQ:TECH) today announced the National Comprehensive Cancer Network (NCCN) decision to include EPI as a recommended test in their Clinical Practice Guidelines in Oncology (NCCN...

TECH : 194.19 (+0.96%)
Analysts Estimate Techne (TECH) to Report a Decline in Earnings: What to Look Out for

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TECH : 194.19 (+0.96%)
Bio-Techne Corp Up 11.3% Since SmarTrend Uptrend Call (TECH)

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on January 8th, 2019 at $147.26. In approximately 3 weeks, Bio-Techne Corp has returned 11.28% as of today's recent price of $163.86.

TECH : 194.19 (+0.96%)
Bio-Techne Introduces CE-SDS PLUS for Maurice(TM) System

Bio-Techne today announced the launch of the CE-SDS PLUS system for its ProteinSimple-branded Maurice(TM) platform. This new system further expands the usability of Maurice's proprietary cartridge and...

TECH : 194.19 (+0.96%)
Bio-Techne Launches Cell and Gene Therapy Portfolio

Bio-Techne announces the launch of their cell and gene therapy portfolio. As a leading manufacturer of GMP-grade ancillary materials and automated instrumentation, Bio-Techne is uniquely able to offer...

TECH : 194.19 (+0.96%)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ +0.11
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar